|
Obagi Nu-Derm Clear 3 | 
enlarge | Brand: Obagi Category: Health And Beauty
List Price: $87.00 Buy New: $69.88 You Save: $17.12 (20%)
New (3) from $69.88
Avg. Customer Rating: 3 reviews Sales Rank: 467
Model: # 3 UPC: 111133111133 EAN: 0111133111133 ASIN: B0015ECRPG
Availability: Usually ships in 1-2 business days
|
| Features:
| Skin Bleaching for Age Spots, Liver Spots & Freckles | | Hydroquinone 4% | | Improves Uneven Skin Tone | | Part of the Obagi Nu-Derm System | | Do NOT use if pregnant, nursing or considering pregnancy |
|
| Similar Items:
|
| Editorial Reviews:
Product Description Obagi Nu-Derm Clear is an essential component of an effective skin care regimen. Formulated with 4% hydroquinone. It improves uneven skin tone and hides age spots, liver spots and freckles on the skin. DO NOT USE THIS PRODUCT IF YOU ARE PREGNANT OR THINKING ABOUT BECOMING PREGNANT.
|
| Customer Reviews:
Great product, stick with it November 19, 2008 This is the only product (And entire line) that reduced my melasma. If you are a first time user, stick with it. The first 2 weeks may be a bit rough - redness peeling etc...but the results are amazing.
Cleared Up My Melasma October 22, 2008 I am 45 and developed melasma on both sides of my face. It is a brownish, freckle like condition related to hormone changes. Obagi Clear was the only thing that cleared up this condition for me. The brown patches are about 90% gone after about 6 weeks of using this product. I have oily skin, and this product did clog my pours on my nose, so I had to discontinue using it on my nose which has some freckling and patchiness. I used Obagi Clear with the Obagi Gel Cleanser and Toner. I added the Exoderm Forte, but that didn't seem to help much.
Obagi Nu-Derm Clear April 27, 2008 Obagi Nu-Derm Clear This is an excellent product!! It has helped to fade the brown spots on my face. I can't recommend it enough! The Nu-Derm line of products take a little getting used to. At first your face will feel very taut, but stick with it. The results are amazing!!
|
|
|
|
| |